According to filings with the U.S. Securities and Exchange Commission, Q’Apel Medical is raising up to $42,130,410.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, King Nelson played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Q’Apel Medical
In the simplest sense, were a company that creates solutions. More specifically, we design novel access device technology for vascular interventions and unmet clinical needs. Because in the precious seconds that surround a stroke emergency, clinicians need technology that delivers. That’s where we come in. Our name was inspired by the Qu’Appelle River, a waterway that winds through Saskatchewan, Canada, highly tortuous in some areas and straight in others. The field of stroke care is similarly riddled with challenges and barriers practically unmatched in any other field of medicine. And over the years, there have been innovators who’ve dared to design solutions for stroke care. But there’s one invaluable ingredient often missing: a commitment to creating what works based specifically and urgently on what’s needed. Were Q’Apel, and we work side by side with neurovascular specialists who have dedicated their careers to serving stroke patients. The result? Solutions that get straight to the heart of what’s needed now, and the momentum to solve what’s coming next.

To learn more about Q’Apel Medical, visit http://qapelmedical.com/

Contact:
King Nelson, Chief Executive Officer
510-738-6255
https://www.linkedin.com/in/king-nelson-449b4812/

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.